Diabetes, Vol 33, Issue 8 732-737, Copyright © 1984 by American Diabetes Association

ARTICLES

A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus

GB Bolli, P De Feo, S De Cosmo, G Perriello, MM Ventura, MM Benedetti, F Santeusanio, JE Gerich and P Brunetti

The safety, reproducibility, and reliability of an insulin infusion test for assessment of adequate glucose counterregulation were evaluated in 18 patients with type I (insulin-dependent) diabetes mellitus. When the test (a 60-min, 30-mU/m2/min insulin infusion) was administered on three separate occasions at 3-4-wk intervals, coefficients of variation for plasma glucose and counterregulatory hormone (glucagon, epinephrine, cortisol, and growth hormone) responses averaged less than 8%. No patient experienced symptoms requiring discontinuation of the test and plasma glucose concentrations increased spontaneously after stopping the insulin infusion. Using objective criteria based on plasma glucose nadirs or postnadir rates of plasma glucose recovery, no patient judged to have adequate glucose counterregulation by the test (postnadir rates of plasma glucose recovery or plasma glucose nadir above 0.4 mg/dl/min and 45 mg/dl) developed severe hypoglycemia (plasma glucose less than 40 mg/dl) during up to 7 mo of intensive insulin therapy, whereas nearly all patients with inadequate counterregulation did. We conclude that this test, when performed in standardized conditions, is safe and reproducible and can reliably predict those patients with type I diabetes who are at risk of developing severe hypoglycemia during intensive insulin therapy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. M. Arbelaez, W. J. Powers, T. O. Videen, J. L. Price, and P. E. Cryer Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition: A Mechanism for Hypoglycemia-Associated Autonomic Failure Diabetes, February 1, 2008; 57(2): 470 - 475. [Abstract] [Full Text] [PDF]

				P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]

				N. R. Gosmanov, E. Szoke, Z. Israelian, T. Smith, P. E. Cryer, J. E. Gerich, and C. Meyer Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans Diabetes Care, May 1, 2005; 28(5): 1124 - 1131. [Abstract] [Full Text] [PDF]

				P. E. Cryer, S. N. Davis, and H. Shamoon Hypoglycemia in Diabetes Diabetes Care, June 1, 2003; 26(6): 1902 - 1912. [Abstract] [Full Text] [PDF]

				V. P. McGregor, J. S. Greiwe, S. Banarer, and P. E. Cryer Limited Impact of Vigorous Exercise on Defenses Against Hypoglycemia: Relevance to Hypoglycemia-Associated Autonomic Failure Diabetes, May 1, 2002; 51(5): 1485 - 1492. [Abstract] [Full Text] [PDF]

				S. Banarer, V. P. McGregor, and P. E. Cryer Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response Diabetes, April 1, 2002; 51(4): 958 - 965. [Abstract] [Full Text] [PDF]

				S. A. Segel, D. S. Paramore, and P. E. Cryer Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes Diabetes, March 1, 2002; 51(3): 724 - 733. [Abstract] [Full Text] [PDF]

				P. E. Cryer and B. P. Childs Negotiating the Barrier of Hypoglycemia in Diabetes Diabetes Spectr, January 1, 2002; 15(1): 20 - 27. [Abstract] [Full Text] [PDF]

				P. E. Cryer Hypoglycemia-associated autonomic failure in diabetes Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1115 - E1121. [Abstract] [Full Text] [PDF]

				S. A. Segel, C. G. Fanelli, C. S. Dence, J. Markham, T. O. Videen, D. S. Paramore, W. J. Powers, and P. E. Cryer Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia Diabetes, August 1, 2001; 50(8): 1911 - 1917. [Abstract] [Full Text] [PDF]

				P. E. Cryer Editorial: Are Gender Differences in the Responses to Hypoglycemia Relevant to Iatrogenic Hypoglycemia in Type 1 Diabetes? J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2145 - 2147. [Full Text]

				C. E. Havlin and P. E. Cryer Hypoglycemia: The Limiting Factor in the Management of Insulin-Dependent Diabetes Mellitus The Diabetes Educator, January 1, 1988; 14(5): 407 - 411. [PDF]